Cell-free DNA in acute stroke
Part of Brain & nervous system, Heart & circulation clinical trials.
This study looks at how a substance called cell-free DNA in the blood changes in people with a large blood clot causing a stroke. It aims to improve understanding of this condition and might help with future treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have had a stroke caused by a large blood clot in the brain.
- Your stroke requires a procedure called mechanical thrombectomy to remove the clot.
- You are at least 18 years old.
- You are not currently on immunotherapy (treatment that affects your immune system).
- You do not have an immune system disease.
- You do not have a body-wide infection at the time of the stroke.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a special CT scan to see how well blood flows in the brain after a stroke patient has had a procedure to remove a clot. The goal is to learn more about recovery and improve future care.
This study looks at tiny blood clots and immune cell activity in people with or without a recent stroke. It aims to find markers that could predict stroke risk or help improve treatment.
This study looks at inflammatory cells in the blood and the blood clot removed from the brain during a stroke emergency. The goal is to better understand the role of inflammation in stroke, which could lead to improved treatments.
This study looks at blood clots removed from the brain during a stroke procedure. Researchers want to understand what the clots are made of and how they relate to your blood tests, treatment success, and recovery.
This trial studies special molecules in the blood (non-coding RNA) in people having an acute ischemic stroke treated with a procedure to remove clots. It may help doctors better understand how the body responds and potentially improve future stroke care.
This study looks at the composition of a stroke blood clot and compares it with blood test results to understand treatment response, stroke cause, and prognosis. It may help doctors better predict outcomes and improve care after ischemic stroke.
Hear when a new Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.